To Counter China, the U.S. Must Fight Malaria

The administration would do well to treat counter-malaria as a blueprint — not just for saving lives, but for winning the competition that defines our era.

Share this story

Women wait to have their children vaccinated during the official ceremony for the launch of the malaria vaccination campaign for children aged between zero and eleven months in Abobo, Abidjan, Ivory Coast, July 15, 2024.

Luc Gnago/Reuters

As the United States and the Chinese Communist Party (CCP) struggle in a trade war, Xi Jinping has sent a consistent message to nations caught between Washington and Beijing: You’ll get a better deal with China if you walk away from America. This geopolitical angling is part of a broader return to great-power competition. But the maneuvering didn’t begin with tariffs. Even before President Donald Trump’s latest actions, Beijing was quietly approaching third-party nations with a simple pitch: You can’t trust America. Work with us instead.

The issue at hand was foreign assistance. One of President Trump’s first moves in his second administration was to restructure U.S. foreign aid. He had good reason. From transgender operas and comic books to DEI musicals, the U.S. Agency for International Development (USAID) had lost its strategic compass. These programs didn’t advance American interests, and some actively undermined them.

MS

About the Author

Michael Sobolik

Michael Sobolik is a senior fellow at the Hudson Institute and the author of Countering China’s Great Game: A Strategy for American Dominance (Naval Institute Press, 2024). Follow him on X @michaelsobolik.

Comments

Advertisement

Advertisement